Checkpoint Therapeutics Inc (CKPT) — Financial Flexibility Index
Checkpoint Therapeutics Inc (CKPT) has a Financial Flexibility Index of -0.65x as of March 2025. Free cash flow of $-11.69 Million (operating CF $-11.69 Million minus capex $0.00) represents -1% of total liabilities ($17.87 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Checkpoint Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Checkpoint Therapeutics Inc across 10 annual periods. See CKPT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Checkpoint Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Checkpoint Therapeutics Inc. For the full company profile including market capitalisation, see Checkpoint Therapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.55x | $-31.10 Million | $-31.10 Million | $20.10 Million | ▲ +40.1% |
| 2023 | -2.58x | $-47.59 Million | $-47.59 Million | $18.43 Million | ▼ -47.1% |
| 2022 | -1.76x | $-57.55 Million | $-57.55 Million | $32.77 Million | ▼ -73.5% |
| 2021 | -1.01x | $-26.31 Million | $-26.31 Million | $25.98 Million | ▲ +55.9% |
| 2020 | -2.29x | $-16.55 Million | $-16.55 Million | $7.22 Million | ▲ +12.9% |
| 2019 | -2.63x | $-21.37 Million | $-21.37 Million | $8.12 Million | ▼ -33.6% |
| 2018 | -1.97x | $-25.80 Million | $-25.80 Million | $13.09 Million | ▲ +16.6% |
| 2017 | -2.36x | $-15.06 Million | $-15.46 Million | $6.37 Million | ▼ -27.9% |
| 2016 | -1.85x | $-6.79 Million | $-9.95 Million | $3.67 Million | ▼ -655.5% |
| 2015 | 0.33x | $1.42 Million | $-1.11 Million | $4.26 Million | — |